03:23 PM EST - Merus Labs International Inc. : announced today that the Company has refinanced its debt obligation previously provided by PDL BioPharma, Inc. which had an outstanding amount owing of $39.5 million U.S., by closing on two new debt instruments: a $30-million Canadian senior credit facility with the Royal Bank of Canada and the Bank of Montreal, and a $10-million Canadian convertible note debenture with a large Canadian institutional investor. Merus Labs International Inc.
shares T.MSL are trading up $0.13 at $1.21.
